Lupus

Approximately one-third of lupus hospitalizations lack post-discharge follow-up care, with “significant disparities” reported among rural and disadvantaged localities, according to Medicare data published in Arthritis Care & Research.

Assistive reproductive therapy is safe and demonstrates “satisfactory outcomes” in patients with systemic lupus erythematous in stable disease, according to data published in Arthritis Research & Therapy.

SCOTTSDALE, Ariz. — Several new drugs and promising therapies, including chimeric antigen receptor T-cell therapy, have ushered in a “lupus renaissance,” said a speaker at the Basic and Clinical Immunology for the Busy Clinician symposium.

Patients with systemic lupus erythematosus receiving anifrolumab are more likely to achieve earlier, more frequent and longer low disease activity, compared with those taking placebo, according to data.

Adverse events and outcomes are more common in pregnant patients with rheumatoid arthritis and systemic lupus erythematosus, and their infants, vs. those without rheumatic diseases, according to data published in Arthritis Care & Research.

Remission should be the primary goal for patients with childhood-onset systemic lupus erythematosus, according to new points to consider for treat-to-target endorsed by the Pediatric Rheumatology European Society.

There is an unmet need among African American youth for more plentiful education and resources regarding lupus, according to data published in BMC Rheumatology.

A self-evidence data platform may help patients with autoimmune diseases and long COVID avoid certain lifestyle and environmental triggers, according to a press release.

The overall risk for incident retinopathy in patients who received hydroxychloroquine for 5 or more years was low but progressively increased with higher doses, according to researchers.